CN102274438A - Oral powder for treating hepatitis B - Google Patents
Oral powder for treating hepatitis B Download PDFInfo
- Publication number
- CN102274438A CN102274438A CN2011102591318A CN201110259131A CN102274438A CN 102274438 A CN102274438 A CN 102274438A CN 2011102591318 A CN2011102591318 A CN 2011102591318A CN 201110259131 A CN201110259131 A CN 201110259131A CN 102274438 A CN102274438 A CN 102274438A
- Authority
- CN
- China
- Prior art keywords
- hepatitis
- oral powder
- herba
- patients
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to 'oral powder for treating hepatitis B', which is rigorous in compatibility and definite in a curative effect of treating hepatitis B virus carriers or patients who suffer from hepatitis, and is used for improving the immunity of patients who suffer from hepatitis B, reducing enzyme quickly and repairing damaged hepatic cells. None of virus variation are found in thousands of patients; and compared with the similar medicaments, the oral powder improves the negative conversion rate of big three positive and small three positive patients, and the negative conversion rate is about 60 percent.
Description
Technical field:
A kind of oral medicinal herb powder for the treatment of hepatitis B.
Background technology:
China has hepatitis B virus carriers 1.2 hundred million now, is hepatitis B big country.The Chinese and western drugs of various treatment hepatitis B is multifarious, and a great variety as lamivudine, Entecavir, for need taking medicine 2 years than Western medicine such as husband pyridines, and produces virus variation, drug resistance etc., and all kinds of Chinese medicines do not have any definite curative effect that has yet.
Summary of the invention:
Determined curative effect of the present invention, the cycle of taking is short, and it is rapid to fall enzyme, the frequence of seroconversion height.It is standby after selected drying and crushing is crossed the sterilization of 100 mesh sieves to get the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Poria, Radix Bupleuri, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Radix Sophorae Flavescentis, Fructus Schisandrae Chinensis, Herba Patriniae.The wherein Radix Astragali, Herba Hedyotidis Diffusae, Rhizoma Polygoni Cuspidati clearing away heat-damp and promoting diuresis, Rhizoma Smilacis Glabrae, Nidus Vespae confirm hepatitis B virus is had better inhibitory action, Radix Bupleuri, Herba Artemisiae Scopariae 'Shugan Lidan ', soothing liver-QI for relieving depression through modern pharmacology, Radix Angelicae Sinensis has the blood circulation promoting and enriching effect, and Radix Sophorae Flavescentis is to suppress product on the HBV virus.It is rapid that enzyme falls in Fructus Schisandrae Chinensis, and Herba Patriniae has repair to impaired hepatocyte; The Radix Astragali, the Rhizoma Atractylodis Macrocephalae can improve immunity, can improve the human body self anti-virus ability.The present invention's " a kind of oral powder that is used for the treatment of hepatitis B " compatibility is rigorous.Treatment hepatitis B virus carriers or hepatitis determined curative effect improve hepatitis B patient autoimmunity, and it is rapid to fall enzyme, repairs impaired hepatocyte, take through over thousands of routine patient, and none example is found virus variation; Big and small three Yang patient negative conversion rate is improved relatively than similar medicine, can reach about 60%.
The specific embodiment:
Be described further below in conjunction with specific embodiment.Get Radix Astragali 30g, Herba Artemisiae Scopariae 30g, Rhizoma Polygoni Cuspidati 15g, Herba Hedyotidis Diffusae 15g, Herba Scutellariae Barbatae 15g, Rhizoma Smilacis Glabrae 15g, Nidus Vespae 15g, Radix Bupleuri 13g, Radix Angelicae Sinensis 12g, Radix Sophorae Flavescentis 15g, Fructus Schisandrae Chinensis 15g, Poria 20g, Rhizoma Atractylodis Macrocephalae 20g, Herba Patriniae 30g are standby after selected drying and crushing is crossed the sterilization of 100 mesh sieves.Hepatitis B patient is obeyed 3g at every turn, every day 3 times, the morning, noon and afternoon after meal eliminating cold for resuscitation water send down, per one course of treatment of February,, can chemically examine liver function about every clothes first quarter moon for the unusual person of ALT, AST, can decline to a great extent, the 1-2 month can take medicine the 2-3 course of treatment for the big and small three Yang patient near normal, as patient 5 certain, man, 34 years old, suffer from the hepatitis B small three positive, ALT, AST are unusual, and bilirubin is unusual,, all turn out cloudy after the course of treatment through clothes " a kind of oral powder that is used for the treatment of hepatitis B ", all are normal.The patient thanks certain, the woman, and 20 years old, suffer from the hepatitis B great three positive, the transaminase raises, and the people becomes thin, and is tired, and through clothes " a kind of oral powder that is used for the treatment of hepatitis B " courses of treatment, great three positive transfers small three positive to, and spirit takes a turn for the better, continuous two courses of treatment of clothes and healing.Patient Chen, the woman, 22 years old, be the hepatitis B great three positive through looking into, the transaminase raises, through clothes " a kind of oral powder that is used for the treatment of hepatitis B " after 20 days the transaminase normal, hepatopathy must heal after two courses of treatment.
Claims (1)
1. oral powder that is used for the treatment of hepatitis B.It is characterized in that prescription compatibility weight ratio is: Radix Astragali 30g, Herba Artemisiae Scopariae 30g, Rhizoma Polygoni Cuspidati 15g, Herba Hedyotidis Diffusae 15g, Herba Scutellariae Barbatae 15g, Rhizoma Smilacis Glabrae 15g, Nidus Vespae 15g, Radix Bupleuri 13g, Radix Angelicae Sinensis 12g, Radix Sophorae Flavescentis 15g, Fructus Schisandrae Chinensis 15g, Poria 20g, Rhizoma Atractylodis Macrocephalae 20g, Herba Patriniae 30g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102591318A CN102274438A (en) | 2011-08-30 | 2011-08-30 | Oral powder for treating hepatitis B |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102591318A CN102274438A (en) | 2011-08-30 | 2011-08-30 | Oral powder for treating hepatitis B |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102274438A true CN102274438A (en) | 2011-12-14 |
Family
ID=45100381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102591318A Pending CN102274438A (en) | 2011-08-30 | 2011-08-30 | Oral powder for treating hepatitis B |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102274438A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552486A (en) * | 2012-03-28 | 2012-07-11 | 王靖敏 | Preparation method of anti-hepatitis B virus oral liquid |
CN103948763A (en) * | 2014-05-21 | 2014-07-30 | 李玮 | Traditional Chinese medicinal composition for treating hepatosis |
-
2011
- 2011-08-30 CN CN2011102591318A patent/CN102274438A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552486A (en) * | 2012-03-28 | 2012-07-11 | 王靖敏 | Preparation method of anti-hepatitis B virus oral liquid |
CN102552486B (en) * | 2012-03-28 | 2013-07-24 | 王靖敏 | Preparation method of anti-hepatitis B virus oral liquid |
CN103948763A (en) * | 2014-05-21 | 2014-07-30 | 李玮 | Traditional Chinese medicinal composition for treating hepatosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101152539A (en) | Traditional Chinese medicine for treating acute icteric hepatitis | |
CN101385815A (en) | Traditional Chinese medicine for treating dementia after stroke | |
CN101342338B (en) | Medicament for treating hepatopathy | |
CN101167893A (en) | Traditional Chinese medicine for treating viral hepatitis | |
CN102389480A (en) | Chinese medicament for treating hepatitis | |
CN101912524B (en) | Schisandra liver-benefiting capsules | |
CN101856487A (en) | Chinese medicament for treating insomnia | |
CN1593571A (en) | Chinese traditional medicine for treating hypertension | |
CN102274438A (en) | Oral powder for treating hepatitis B | |
CN103463557B (en) | A kind of Chinese medicinal formulae for the treatment of hepatitis B | |
CN103100035B (en) | Traditional Chinese medicine (TCM) decoction for treating globus hysteriocus | |
CN102552512A (en) | Traditional Chinese medicine used for treating hepatitis B | |
CN101167969A (en) | Traditional Chinese medicine for treating meniere's syndrome | |
CN102266517B (en) | Oral powder for treating hepatitis B | |
CN1385191A (en) | Medicine for treating liver disease | |
CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
CN101152540A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN101069731A (en) | Ready-made Chinese medicine jelly-pills for treating hypertension | |
CN1994416B (en) | Orally administered Chinese medicine for treating amenorrhvea | |
CN101152489A (en) | Traditional Chinese medicine for treating acute hepatitis of children | |
CN101152542A (en) | Traditional Chinese medicine for treating cholestatic hepatitis | |
CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
CN101129623A (en) | Traditional Chinese medicine for treating insomnia | |
CN1965979A (en) | Medicament for treating hepatitis B | |
CN101152452A (en) | Traditional Chinese medicine for treating advanced glaucoma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
DD01 | Delivery of document by public notice |
Addressee: Mo Guisen Document name: Notification that Application Deemed to be Withdrawn |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111214 |